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Objectives: The delayed separation of whole blood can influence the concen-
trations of circulating blood components, including metabolites and cytokines.
The aim of this study was to determine whether clinical-biochemistry analytes
can be used to assess the delayed separation of whole blood.
Methods: We investigated the plasma and serum concentrations of five clinical-
biochemistry analytes and free hemoglobin when the centrifugation of whole
blood stored at 4C or room temperature was delayed for 4 hours, 6 hours,
24 hours, or 48 hours, and compared the values with those of matched samples
that had been centrifuged within 2 hours after whole-blood collection.
Results: The inorganic phosphorus (IP) levels in the plasma and serum samples
were elevated  1.5-fold when whole-blood centrifugation was delayed at room
temperature for 48 hours. Furthermore, the IP levels in the plasma samples
showed excellent assessment accuracy [area under the receiver-operating-
characteristic curve (AUC) > 0.9] after a 48-hour delay in whole-blood separa-
tion, and high sensitivity (100%) and specificity (95%) at an optimal cutoff point.
The IP levels in the serum samples also exhibited good assessment accuracy
(AUC > 0.8), and high sensitivity (81%) and specificity (100%). The potassium (Kþ)
levels were elevated 1.4-fold in the serum samples following a 48-hour delay in
whole-blood separation. The Kþ levels showed excellent assessment accuracy
(AUC > 0.9) following a 48-hour delay in whole-blood separation, and high
sensitivity (95%) and specificity (91%) at an optimal cutoff point.
Conclusion: Our study showed that the IP and Kþ levels in the plasma or serum
samples could be considered as putative indicators to determine whether whole-
blood separation had been delayed for extended periods..
ase Control and Prevention. Published by Elsevier Korea LLC. This is an open access article
reativecommons.org/licenses/by-nc-nd/4.0/).
Delayed Separation of Whole Blood 911. Introduction
Plasma and serum samples have been used to di-
agnose a variety of diseases, predict prognoses, or
identify disease-related biomarkers [1e4]. These sam-
ples are obtained by centrifugation after anticoagulation
(using an anticoagulant, such as EDTA or heparin) and
coagulation of whole blood, respectively [4]. Currently,
the delay between collection and whole-blood centrifu-
gation can influence the concentrations of circulating
blood components, including metabolites and cytokines,
due to prolonged contact with cells [5e10]. Hemolysis,
which results in the release of hemoglobin and other
intracellular components from red blood cells, might
also occur when whole-blood processing is delayed [11].
Therefore, plasma and serum samples should be pre-
pared as soon as possible after whole-blood collection
by venipuncture [6]. However, whole-blood separation
can be delayed for various reasons.
In laboratory tests (such as clinical biochemistry and
hematology) routinely performed for diagnosis or pre-
diction of prognosis in a clinical laboratory, the main
causes of laboratory errors are preanalytical variables
involved with biospecimen collection, processing, and
storage conditions [12e14]. Several studies demon-
strated that delayed whole-blood separation affects the
plasma and serum concentrations of biochemical ana-
lytes [e.g., alanine aminotransferase (ALT), aspartate
aminotransferase (AST), inorganic phosphorus (IP),
potassium (Kþ), and lactate dehydrogenase (LDH)]
[6e9]. In this study, we investigated whether clinical-
biochemistry analytes can be used to assess the
delayed whole-blood separation. Moreover, to deter-
mine whether hemolysis influences variations in the
tested analytes, we also investigated the variation of free
plasma and serum hemoglobin concentrations induced
by delayed whole-blood separation.2. Materials and methods
2.1. Sample preparation
Whole-blood samples were collected from 135 par-
ticipants into Vacutainer serum-separator tubes (Becton
Dickinson, East Rutherford, NJ, USA) and plasma-
separator tubes (Becton Dickinson). Each sample was
divided into several 1.5-mL tubes (300 mL  5 tubes),
and stored at 4C or room temperature until centrifu-
gation for 15 minutes at 1,600g. Among the samples,
one aliquot was centrifuged within 2 hours after whole-
blood collection, and other aliquots were centrifuged at
4 hours, 6 hours, 24 hours, or 48 hours after the first
centrifugation. (These represent “delay times” in the
separation of plasma and serum.) The plasma and serum
samples were separated, and then stored at 70C
before being used for clinical-biochemistry or enzyme-
linked immunosorbent assay experiments.2.2. Sample analysis
Concentrations of ALT (U/L), AST (U/L), IP (mg/
dL), Kþ (mmol/L), and LDH (U/L) in the plasma and
serum samples were determined using an automated
chemistry analyzer (Roche Modular P800 autoanalyzer;
Roche Diagnostics GmbH, Mannheim, Germany) with
the appropriate reagents (Roche Diagnostics) according
to the recommended protocol. Free-hemoglobin con-
centrations (mg/dL) in the plasma and serum samples
were measured using the QuantiChrom Hemoglobin
Assay Kit (Bioassay Systems, Haywood, CA, USA)
according to the manufacturer’s recommendations. All
samples were measured in duplicate.
2.3. Statistical analysis
The analyte concentrations were expressed as
means  standard deviation. To identify analytes whose
concentrations increased or decreased with statistical
significance in plasma and serum samples following
delayed whole-blood separation, we performed a paired
two-tailed t test and a repeated-measures analysis of
variance using SPSS version 13.0 (SPSS Inc., Chicago,
IL, USA).
To determine whether the plasma or serum concen-
trations of clinical-biochemistry analytes can be used for
assessing delayed whole-blood separation, we carried
out receiver-operating-characteristic (ROC) curve anal-
ysis using MedCalc software for Windows (MedCalc
Software, Ostend, Belgium). The area under the ROC
curve (AUC) values < 0.7, between 0.7 and 0.8, be-
tween 0.8 and 0.9, and > 0.9 were considered as poor,
fair, good, and excellent, respectively. Statistical sig-
nificance was determined as p < 0.05.3. Results
3.1. Effect of delayed whole-blood separation on
the stability of clinical-biochemistry
analytes
We evaluated the concentration changes of ALT,
AST, IP, Kþ, and LDH in the plasma and serum samples
when the centrifugation of whole blood stored at 4C or
room temperature was delayed for 4 hours, 6 hours, or
24 hours as compared to the separation being performed
within 2 hours after whole-blood collection (baseline;
Tables 1 and 2). The concentrations of AST, Kþ, and
LDH increased slightly (3.7e21.2%), but significantly
(p < 0.05), in the plasma samples when whole-blood
centrifugation was delayed at 4C for 24 hours. Addi-
tionally, the AST and LDH concentrations changed
more markedly at room temperature as compared to
those at 4C. The IP and LDH levels in the plasma were
elevated > 20% relative to baseline when separation
was delayed for 24 hours at room temperature. In the
serum samples, the Kþ and LDH concentrations
increased when whole-blood centrifugation was delayed
Table 1. Concentration variations of five clinical-biochemistry analytes in the plasma samples after delayed whole-blood separation.
Analyte
Delay time at 4C (n Z 57) Delay time at room temperature (n Z 62)
0 h (baseline) 4 h 6 h 24 h p a 0 h (baseline) 4 h 6 h 24 h p a
ALT b 23.67  18.74 23.47  18.40 23.26  18.53 23.54  18.30 0.917 24.40  13.57 23.94  13.68 24.03  13.73 24.21  13.66 0.865
(U/L) (e0.8) (e1.7) (e0.5) (e1.9) (e1.5) (e0.8)
AST b 26.54  18.95 26.35  17.83 26.39  18.16 27.53  17.79 * 0.716 24.27  14.17 24.13  14.08 24.37  14.02 25.47  14.54 * 0.639
(U/L) (e0.7) (e0.6) (þ3.7) (e0.6) (þ0.4) (þ4.9)
IP b 3.33  0.66 3.28  0.67 * 3.25  0.64 * 3.37  0.71 0.780 3.25  0.77 3.16  0.77 * 3.17  0.77 * 4.10  1.15 * < 0.001
(mg/dL) (e1.5) (e2.6) (þ1.1) (e2.8) (e2.6) (þ26.3)
Kþ b 22.09  2.32 22.42  2.23 * 22.79  1.96 * 26.78  3.34 * < 0.001 25.35  3.15 24.13  3.05 * 23.77  3.66 * 24.37  3.56 * 0.060
(mmol/L) (þ1.5) (þ3.2) (þ21.2) (e4.8) (e6.2) (e3.9)
LDH b 336.74  100.80 336.26  98.15 337.82  98.65 396.61  145.78 * 0.008 311.29  82.07 313.58  81.74 * 314.81  81.03 * 382.34  95.58 * < 0.001
(U/L) (e0.1) (þ0.3) (þ17.8) (þ0.7) (þ1.1) (þ22.8)
aSignificance measured using repeated-measures analysis of variance; bNumbers in brackets represent percentage change, with a “þ” for an increase and a “e” for a decrease relative to baseline. * Indicates p < 0.05, calculated
using a paired two-tailed t test. ALT Z alanine aminotransferase; AST Z aspartate aminotransferase; IP Z inorganic phosphorous; Kþ Z potassium; LDH Z lactate dehydrogenase.
Table 2. Concentration variations of five clinical-biochemistry analytes in the serum samples after delayed whole-blood separation.
Analyte
Delay time at 4C (n Z 55) Delay time at room temperature (n Z 58)
0 h (baseline) 4 h 6 h 24 h p a 0 h (baseline) 4 h 6 h 24 h p a
ALT b 22.64  18.19 22.29  18.06 * 22.29  17.96 22.89  17.97 0.876 22.41  14.14 22.34  13.91 22.16  13.89 22.81  14.39 0.823
(U/L) (e1.5) (e1.5) (þ1.1) (e0.3) (e1.2) (þ1.8)
AST b 25.13  15.80 24.45  15.18 * 24.58  15.24 * 24.91  15.02 0.837 23.40  11.50 23.36  11.22 23.88  11.16 23.36  9.55 0.819
(U/L) (e2.7) (e2.2) (e0.9) (e0.1) (þ2.1) (e0.1)
IP b 3.45  0.62 3.43  0.62 * 3.43  0.61 3.49  0.60 * 0.647 3.48  0.82 3.26  0.81 * 3.15  0.81 * 3.71  1.23 0.007
(mg/dL) (e0.7) (e0.6) (þ1.0) (e6.5) (e9.4) (þ6.6)
Kþ b 4.42  0.51 5.01  0.52 * 5.39  0.58 * 9.60  2.00 * < 0.001 4.28  0.46 4.24  0.49 4.27  0.52 4.47  0.60 * 0.079
(mmol/L) (þ13.4) (þ22.1) (þ117.3) (e0.8) (e0.2) (þ4.5)
LDH b 336.93  99.78 338.56  97.07 339.02  97.32 360.60  109.54 * 0.269 318.55  88.11 333.03  85.03 * 335.97  85.17 * 340.36  81.55 * 0.213
(U/L) (þ0.5) (þ0.6) (þ7.0) (þ4.5) (þ5.5) (þ6.8)
aSignificance measured using repeated-measures analysis of variance; bNumbers in brackets represent percentage change, with a “þ” for an increase and a “e” for a decrease relative to baseline. * Indicates p < 0.05, calculated











Delayed Separation of Whole Blood 93at 4C or room temperature for 24 hours, with LDH
levels increasing with delay times at both 4C and room
temperature. Moreover, the extent of the increase in Kþ
concentration was greater at 4C as compared to room
temperature in both the plasma and serum samples.
Next, we assessed how the plasma and serum con-
centrations of five clinical-biochemistry analytes varied
after whole-blood centrifugation was delayed at room
temperature for 48 hours as compared to the concen-
trations in the samples separated within 2 hours after
whole-blood collection (using samples distinct from
those used in the aforementioned experiments). The
concentrations of all analytes increased with the 48-hour
delay (Figure 1). Among these, the IP level increased
nearly twofold in both the plasma and serum samples.
The LDH and Kþ increased by 1.4-fold in the plasma
and serum samples, respectively.3.2. Accuracy analysis of clinical-biochemistry-
analyte levels in the assessment of delayed
whole-blood separation
To determine whether the plasma and serum con-
centrations of clinical-biochemistry analytes can be used
for assessing delay in whole-blood separation, we car-
ried out ROC-curve analysis on the clinical-
biochemistry analytes that increased significantly in
the plasma and serum samples following a 48-hour
delay in whole-blood separation (Table 3).
Among the tested analytes, the plasma concentration
of IP exhibited excellent assessment accuracy
(AUC Z 0.999) for delayed whole-blood separation.
Additionally, the sensitivity (100%) and specificity
(95%) were close to 100% at an optimal cutoff point of
4.3 mg/dL. The serum concentration of IP also showed
good assessment accuracy (AUC Z 0.856), and high
sensitivity (81%) and specificity (100%) at an optimal
cutoff point of 4.5 mg/dL. The Kþ levels showed
excellent assessment accuracy (AUCZ 0.965), and high
sensitivity (95%) and specificity (91%) at an optimal
cutoff point of 4.7 mmol/L in the serum samples.Figure 1. Concentration changes of five clinical-biochemistry ana
separation was delayed at room temperature for 48 hours as com
* Indicates p < 0.05, calculated using a paired two-tailed t test.
transferase; IP Z inorganic phosphorous; Kþ Z potassium; LDH3.3. Change in free-hemoglobin concentration
following delayed whole-blood separation
We measured the free-hemoglobin concentrations in
the plasma and serum samples after whole-blood
centrifugation was delayed at 4C or room temperature
for 4 hours, 6 hours, or 24 hours, and compared these
values with the corresponding concentrations in samples
separated within 2 hours after whole-blood collection
(Table 4). The free-hemoglobin concentrations
increased from 6.9% to 21.2% in both the plasma and
serum samples when whole-blood separation was
delayed at 4C and room temperature for 24 hours
(except in the case of the serum samples at room tem-
perature), and tended to increase relative to the delay
time.
We also compared the free-hemoglobin concentra-
tions in the plasma and serum samples (samples
distinct from those used previously) obtained after
whole-blood centrifugation was either delayed at room
temperature for 48 hours or performed within 2 hours
after whole-blood collection. The concentration of free
hemoglobin increasedw1.2-fold in the plasma, but not
in the serum samples. At baseline and after a 48-hour
delay, the free-hemoglobin concentrations in the
plasma were 46.05  22.57 mg/dL and
56.39  28.78 mg/dL, and in the serum were
58.90  36.41 mg/dL and 57.75  32.08 mg/dL,
respectively (data not shown).4. Discussion
We investigated how the plasma and serum con-
centrations of clinical-biochemistry analytes were
changed by delayed whole-blood separation. Previous
studies showed that the plasma or serum concentrations
of ALT, AST, IP, Kþ, and LDH were slightly, but
significantly, changed by delayed whole-blood separa-
tion [6e9]. The ALT concentration was elevated by
1.5% in serum samples obtained from whole bloodlytes in (A) plasma and (B) serum samples when whole-blood
pared to separation within 2 hours of whole-blood collection.
ALT Z alanine aminotransferase; AST Z aspartate amino-
Z lactate dehydrogenase.
Table 4. Free-hemoglobin concentrations after delayed whole-blood separation.
Storage temperature Sample
Delayed time
p a0 h (baseline) 4 h 6 h 24 h
4C Plasma (mg/dL) 43.89  18.68 48.07  19.07 * 49.76  21.40 * 51.05  20.48 * 0.856
n Z 29 b (þ9.5) (þ13.4) (þ16.3)
Serum (mg/dL) 46.62  21.06 47.71  17.84 49.20  19.30 56.48  20.32 * 0.108
n Z 27 b (þ2.3) (þ5.5) (þ21.2)
Room temperature Plasma (mg/dL) 47.12  31.35 47.33  29.33 48.05  28.31 50.39  35.15 * 0.835
n Z 68 b (þ0.5) (þ2.0) (þ6.9)
Serum (mg/dL) 51.14  33.62 47.67  31.56 47.66  33.84 45.90  33.73 0.938
n Z 68 b (e6.8) (e6.8) (e10.2)
aSignificance measured using repeated-measures analysis of variance; bNumbers in brackets represent percent change, with a “þ” for an increase and a “e”
for a decrease relative to baseline. * Indicates p < 0.05, calculated using a paired two-tailed t test.
Table 3. Accuracy of clinical-biochemistry-analyte levels in the assessment of delayed whole-blood separation at room
temperature for 48 hours as compared with levels in samples separated within 2 hours of whole-blood collection.
Sample Analyte Optimal cutoff point
Area under the
ROC curve Sensitivity (%) Specificity (%) p
Plasma ALT > 19.0 U/L 0.629 52.4 76.2 0.141
AST > 23.0 U/L 0.706 52.4 90.5 0.013
IP > 4.3 mg/dL 0.999 100.0 95.2 < 0.001
Kþ > 22.3 mmol/L 0.765 95.2 57.1 < 0.001
LDH > 409.0 U/L 0.863 76.2 85.7 < 0.001
Serum ALT > 13.0 U/L 0.576 71.4 42.9 0.398
AST > 16.0 U/L 0.583 81.0 33.3 0.355
IP > 4.5 mg/dL 0.856 81.0 100.0 < 0.001
Kþ > 4.7 mmol/L 0.965 95.2 90.5 < 0.001
LDH > 328.0 U/L 0.686 81.0 52.4 0.025
ALTZ alanine aminotransferase; AST Z aspartate aminotransferase; IPZ inorganic phosphorous; KþZ potassium; LDH Z lactate dehydrogenase;
ROC Z receiver operating characteristic.
94 J.-E. Lee, et alstored at room temperature for 24 hours as compared to
30 minutes [8]. By contrast, the ALT concentrations in
plasma samples separated from whole blood stored at
4C or room temperature for up to 24 hours did not
differ significantly from that observed in samples
separated immediately after collection [6,7]. The con-
centrations of AST (3.0%) and LDH (8.9%) were
slightly higher in serum samples prepared from whole
blood stored at room temperature for 24 hours as
compared to that observed in samples obtained from
whole blood stored for 30 minutes [8]. The Kþ con-
centration increased in plasma and serum samples ob-
tained from whole blood stored at room temperature for
up to 56 hours [6]. The IP concentrations changed in
plasma (7.0%) and serum samples (3.8%) after whole-
blood separation was delayed at room temperature for
24 hours as compared with the concentrations
measured after immediate separation [9]. Our results
were generally consistent with those reported previ-
ously. Additionally, we demonstrated that the IP con-
centration was elevated w2-fold in the plasma and
serum samples following a 48-hour delay in separation
at room temperature, and displayed high assessment
accuracy, sensitivity, and specificity for a 48-hourdelay in separation by ROC-curve analysis. The Kþ
concentration also displayed high assessment accuracy,
sensitivity, and specificity in the serum samples. These
findings suggest that the IP and Kþ concentrations can
serve as potential indicators to determine whether
whole-blood centrifugation had been delayed for
extended periods.
The ALT, AST, Kþ, and LDH concentrations are
elevated in hemolytic plasma [15] or serum samples
[14]. These analytes and free hemoglobin were elevated
slightly, but significantly, in the plasma or serum sam-
ples when whole-blood centrifugation was delayed at
4C or room temperature for up to 48 hours. Thus, the
ALT, AST, Kþ, and LDH concentrations may be
affected by hemolysis.
In conclusion, our findings indicate that the IP and
Kþ concentrations in the plasma or serum samples could
be used to predict whether or not whole-blood separa-
tion was delayed for extended periods.Conflicts of interest
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